Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol RBP4 contributors: mct - updated : 13-11-2024
HGNC name retinol binding protein 4, plasma
HGNC id 9922
ASSOCIATED DISORDERS
corresponding disease(s) RDCCAS , MCOPBC10
related resource Retinal Information Network
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
constitutional     --over  
in type 2 diabetes
tumoral     --low  
silencing by methylation in esophageal squamous cell carcinoma
constitutional     --low  
maternal and umbilical cord serum RBP4 levels were lower in patients with preeclampsia than in normal pregnant women in the third trimester of pregnancy
constitutional     --low  
in familial partial lipodystrophy
tumoral     --over  
in ovarian cancer cells promoting cancer cell migration and proliferation
constitutional     --over  
in insulin resistance and contributes to increased diabetes risk
constitutional     --over  
in liver, subcutaneous adipose tissue (SAT), and visceral adipose tissue (VAT) in morbidly obese subjects
Susceptibility
  • to childhood obesity and cardiovascular risk factors
  • Variant & Polymorphism SNP
  • SNP rs3758538 is associated with obesity
  • Candidate gene lowering RBP4 is a new strategy for treating tye 2 diabetes
    Marker
  • RBP4 is a serum marker for ovarian cancer
  • Therapy target
    SystemTypeDisorderPubmed
    diabete  
    lowering RBP4 is a new strategy for treating tye 2 diabetes
    obesity  
    retinol-dependent metabolic function of RBP4 that may have important implications for the treatment of obesity
    neuromuscular  
    lowering RBP4 levels might serve as a promising therapeutic approach for prevention and treatment of muscle atrophy
    obesity  
    could be a molecular bridge between obesity and cancers and a potential target for treating obese cancer patients
    diabetetype 2 
    lowering RBP4 could be a new strategy for treating type 2 diabetes with diabetic retinopathy (DR)
    ANIMAL & CELL MODELS